| Term 
 | Definition 
 
        | -Levodopa/Carbidopa (Sinemet) |  | 
        |  | 
        
        | Term 
 
        | Levodopa/Carbidopa (Sinemet) |  | Definition 
 
        | -Dopamine's immediate precursor (L-Dopa) -Readily transported across BBB
 -prevents conversion of LDopa to dop. in the periphery
 -allows L-Dopa to reach CNS in bigger amts.
 -reduces rigidity and tremors
 -causes "On/Off" Phenomenon
 |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of Levodopa/Carbidopa (Sinemet) |  | Definition 
 
        | -CNS: dyskinesia, visual/audio hallucinations -Peripheral: N/V, Tachy, Hypo, mydriasis, brown saliva/urine
 |  | 
        |  | 
        
        | Term 
 
        | Levodopa/Carbidopa (Sinemet) interaction drugs |  | Definition 
 
        | -Pyridoxine (B6): increases breakdown -MAOI: increase catecholamine stim = HTN crisis
 -Antipsychotic agents: parkinsonian syndr.
 |  | 
        |  | 
        
        | Term 
 
        | Dopamine Receptor Agonists |  | Definition 
 
        | -Pramipexole (Mirapex) -Ropinirole (Requip)
 |  | 
        |  | 
        
        | Term 
 
        | Pramipexole (Mirapex) Ropinirole (Requip)
 |  | Definition 
 
        | -Dopamine Receptor Agonists -req. frequent dosing
 -eliminated renally
 -Adverse Effects: dyskinesia, orthostatic hypo, hallucination, somnolence, dizziness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -MAO-B inhibitors -inhibits breakdown of dopamine (MAO-B)
 -Does NOT inhibit MAO-A
 -improves motor function in parkinson's
 -Seligine forms Amphetamine at metabolite, VERY limited use
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Tolcapone (Tasmar) -Entacapone (Comtan)
 |  | 
        |  | 
        
        | Term 
 
        | Tolcapone (Tasmar) Entacapone (Comtan)
 |  | Definition 
 
        | -COMT Inhibitors -Decrease the peripheral metabolism of L-Dopa
 -Reduces "off" periods
 -used in combo w/ levodopa/carbidopa
 -Have to monitor Liver Enzymes b/c Tolcapone can cause fulminant hepatic necrosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Nondopaminergic agents -helpful for levodopa-induced dyskinesia
 -blockade of excitatory NMDA receptors
 |  | 
        |  | 
        
        | Term 
 
        | Benztropine (Cogentin) Trihexyphenidyl
 |  | Definition 
 
        | -Antimuscarinic agents -Adjuvant role in reducing tremor
 -anticholinergic side effects
 |  | 
        |  | 
        
        | Term 
 
        | Typical Antipsychotic Agents (Low Potency) |  | Definition 
 
        | -Chlorpromazine (Thorazine) -Procholorperazine (Compazine)
 -Promethazine (Phengren)
 Thioridazine (Mellaril)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Aripiprazole (Abilify) -Clozapine (Clozaril)
 -Olanzapine (Zyprexa)
 -Quetiapine (Seroquel)
 -Risperidone (Risperdal)
 -Ziprasidone (Geodon)
 |  | 
        |  | 
        
        | Term 
 
        | Typical Antipsychotics (High Potency) |  | Definition 
 
        | -Fluphenazine (Prolixin) -Haloperidol (Haldol)
 -Pimozide (Orap)
 -Thiothixene (Navaine)
 |  | 
        |  | 
        
        | Term 
 
        | Typical Antipsychotics Mechanism |  | Definition 
 
        | -block dopamine receptors in brain and periphery -antipsychotic activity involves antagonism of mesolimbic system
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Block dopamine receptors in brain and periphery (lower affinity for D2) -antipsychotic activity involves antag of mesolimbic system
 -unique action through inhibition of serotonin receptors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -reduce positive symptoms of halluc and delusions -Negative s/s of blunted affect, anhedonia, apathy, and impaired attention not as responsive to typical antipsychotics
 -actions take several weeks
 |  | 
        |  | 
        
        | Term 
 
        | Antipsychotic Therapeutic Uses |  | Definition 
 
        | -Schizophrenia -Prevention of severe N/V
 -Tranquilizers
 -Chronic p! w/severe anxiety
 -Intractable hiccups
 -Motor and phonic tics of Tourette's disorder
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -GABA meatab inhibitor -competitive inhibitor of GABA transporters in neurons and glia
 -Selective for GAT-1
 -inc GABA conc. for receptor binding
 -enhances inhibitory activity
 -anticonvulsant
 -used for Epilepsy
 -metab by CYP450 enzymes(liver)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GABA Metab Inhibitor -irreversibly inhibits GABA-transaminase
 -inhibition results in inc levels of GABA in CNS
 -used for Epilepsy
 -eliminated unchanged in urine
 -BLACK BOX WARNING: permanent vision loss!
 |  | 
        |  | 
        
        | Term 
 
        | GABA Metabolism Inhibitors |  | Definition 
 
        | -Vigabatrin (Sabril) -Tiagabine (Gabitril)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -most widely used anxiolytic drugs -targets GABA-A (high aff/selective)
 -results in freq opening of adjacent chloride channels = enhanced hyperpol=further inhibits neuronal firing
 -used as anticonvulsant, anterograde amnesia, sedative, mm relaxant, alcohol withdrawals, sleep disorders
 |  | 
        |  | 
        
        | Term 
 
        | Short Acting Benzo's (3-8 hours)
 |  | Definition 
 
        | -Midazolam = preanesthetic, IV general anesthetic -Clorazepate = anxiety disorders, seizures
 -Triazolam = insomnia
 |  | 
        |  | 
        
        | Term 
 
        | Intermediate Acting Benzo's (11-20 Hours)
 |  | Definition 
 
        | -Alprazolam = anxiety, phobias -Lorazepan = anxiety, epilepsy, IV general anesthetic
 -Estazolam = insomnia
 -Temazepam = insomnia
 |  | 
        |  | 
        
        | Term 
 
        | Long Acting Benzo's (1-3 days)
 |  | Definition 
 
        | -Chlordiazepoxide = anxiety, EtOH withdrawl -Clonazepam = seizures
 -Diazepam = anxiety, epilepsy, mm relaxant, IV anesth, EtOH w/drawal
 -Flurazepam = insomnia
 -Quazepam = insomnia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzo ANTAGonist (GABA-A) -rapidly reverses benzo effects
 -IV only    -Short half life (1hour)
 -may precipitate withdrawal or cause seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypnotic Agent -used to treat insomnia
 -no anticonvulsant/mm relaxing properties
 -rapid onset/shorter half life (2-3hrs)
 -metab by CYP450 (liver)
 -causes severe drowsiness that can last
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypnotic Agent -similar to Zolpidem
 -treat insomnia
 -fewer residual effects on psychomotor and cognitive funct
 -rapid elim
 -half life= <1hour
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anxiolytic Agent -used for generalized anxiety
 -mediated through serotonin recept.
 -lacks mm relaxant and anticonvulsant props
 -minimal sedation, dependence unlikely
 -slow onset of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypnotic Agent -treat insomnia   -GABA-A AGONIST
 -rapidly absorbed, extensively metab
 -6 hour half life
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypnotic Agent -antihistamine and antiemetic
 -low tendency for habituation
 -used for allergice reaction but can be used to treat insomnia
 |  | 
        |  | 
        
        | Term 
 
        | Ultrashort Acting Barbituates (5-15 minutes)
 |  | Definition 
 
        | -Thiopental = Anesth. induction, emergency seizure Tx -Methohexital = Anesth. induction and short term maintenance
 |  | 
        |  | 
        
        | Term 
 
        | Short Acting Barbituates (3-8 hours)
 |  | Definition 
 
        | -Pentobarbital -Secobarbital
 -Amobarbital
 = insomnia, preop sedation, emerg seizure Tx
 |  | 
        |  | 
        
        | Term 
 
        | Long Acting Barbituates (days)
 |  | Definition 
 
        | Phenobarbital - Tx of seizures, epilepsy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Barbituate (short acting 1-4 hrs) -suppression of neuronal activity
 -inc efficacy of GABA by inc open time of Cl channel
 -direct GABA-A activation
 -noncompetitive ANTAG at AMPA recep
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Barbituate (Long acting days) -minimal neuronal suppresion
 -inc efficacy of GABA-A by inc open time of Cl channels --> dec. excitability
 -noncompetitve ANTAG at AMPA rec
 -Used for: partial Seizures (simple), tonic clonic, absence seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GABA-A AGONIST -Tx of spasticity assoc w/motor neuron diseases (MS)
 -modest vol of distribution
 -does not cross BBB
 -half life = 5 hours
 -renal clearance
 -can give an intrathecal line of it
 -withdrawal can cause hyperspasticity or Rhabdo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -CNS depressant produces sedation and hypnosis -inc GABA-A Cl channels and inhibits excitatory effects of glutamate at NMDA receptors
 -metab by liver
 -synergistic w/ sedatives
 -Benzo's used to tx withdrawals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used to treat alcoholism -makes patient feel sick when they drink but have to take chronically
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Noncompetitive NMDA receptor ANTAGonist -may slow Ca2+ influx and nerve damage
 -used in Tx of Alzheimer's
 -min metab via liver, excreted mainly in urine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Noncompetitive NMDA receptor ANTAGonist -blocks glutamate's effect=inhibition
 -used in combo with levodopa to tx dyskinesias in parkinson disease
 -excreted in urine
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin Storage Inhibitors |  | Definition 
 
        | Dextroamphetamine/ Amphetamine (Adderall) -Methylphenidate (Ritalin)
 -Modafinil (Provigil)
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin Degradation Inhibitor (MAOI's)
 |  | Definition 
 
        | -Phenelzine (Nardil) -Tranylcypromine (Parnate)
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin Reuptake Inhibitors |  | Definition 
 
        | Tricyclic Antidepressants -Imipramine (Toranil)
 -Amitriptyline (Elavil)
 -Nortriptyline (Pamelor)
 |  | 
        |  | 
        
        | Term 
 
        | Selective Serotonin Reuptake Inhibitors (SSRI's) |  | Definition 
 
        | -Fluoxetine (Prozac) -Citalopram (Celexa)
 -Paroxetine (Paxil)
 -Sertraline (Zoloft)
 -Escitalopram (Lexapro)
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin-Norepinephrine Reuptake Inhibitors (SNRI's) |  | Definition 
 
        | -Venlafaxine (Effexor) -Desvenlafaxine (Pristiq)
 -Duloxetine (Cymbalta)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Bupropion (Wellbutrin or Zyban) -Mirtazapine (Remeron)
 -Trazodone (Desyrel)
 |  | 
        |  | 
        
        | Term 
 
        | Bupropion (Wellbutrin or Zyban) |  | Definition 
 
        | -Inhibits DA & NE reuptake' min 5HT effects -used for major depressive disorder and smoking cessation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Antidepressant -Inhibits 5HT and A andrenergic receptors
 -Increase 5HT/NE neurotransmission
 -used for major depressive disorder, appetite stim
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Antidepressant -Inhibits 5HT reuptake transporter and blocks 5HT2a receptors
 -used for insomnia, major depressive disorder
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin Receptor Agonists |  | Definition 
 
        | Triptans: -Sumatriptan (Imitrex)
 -Zolmitriptan (Zomig)
 -Rizatriptan (Maxalt)
 Activate 5HT1D and 1B receptors
 -->vasoconstr of intracranial vasc
 --used for migraines
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin Receptor Antagonist |  | Definition 
 
        | 5HT3 receptor antag -Ondansetron (Zofran)
 -Granisetron (Kytril)
 -Dolasetron (Anzemet)
 -Anti emetic: used for cancer chemo and refractory nausea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lithium Carbonate (Lithobid or Eskalith) |  | 
        |  | 
        
        | Term 
 
        | Dextroamphetamine/ Amphetamine (Adderall) -Methylphenidate (Ritalin)
 -Modafinil (Provigil)
 |  | Definition 
 
        | Serotonin Storage Inhibitors -Displace 5HT from storage vesicles
 -used for Atypical depression, depression in elderly, narcolepsy
 |  | 
        |  | 
        
        | Term 
 
        | -Phenelzine (Nardil) -Tranylcypromine (Parnate)
 |  | Definition 
 
        | MAOI -Inhibits breakdown of DA, 5HT, NE
 -used for atypical depression, not considered 1st line therapy
 -Adverse effects: HTN crisis, Serotonin syndr.
 |  | 
        |  | 
        
        | Term 
 
        | Imipramine (Toranil) Amitriptyline (Elavil)
 Nortriptyline (Pamelor)
 |  | Definition 
 
        | Tricyclic Antidepressants -Inhibit reuptake of NE and 5HT from cleft by inhibiting transporters
 -increase levels of 5HT/NE in cleft
 -used for MDD, panic disorder, bed wetting
 |  | 
        |  | 
        
        | Term 
 
        | Fuoxetine (Prozac) Citalopram (Celexa)
 Paroxetine (Paxil)
 Sertraline (Zoloft)
 Escitalopram (Lexapro)
 |  | Definition 
 
        | SSRI's -selectively inhibit reuptake of 5HT by inhibiting transporter
 -used for MDD (1st line), panic, anxiety, OCD, PTSD
 |  | 
        |  | 
        
        | Term 
 
        | Venlafaxine (Effexor) Desvenlafaxine (Pristiq)
 Duloxetine (Cymbalta)
 |  | Definition 
 
        | SNRI's -Venlaf. & Desvenl. block NE/5HT tranporters in conc dependent manner
 -Duloxetine blocks NE/5HT reuptake transporters
 -used for MDD, anxiety, diabetic neruo, fibromyalgia
 |  | 
        |  | 
        
        | Term 
 
        | Enhance Na+ Channel-Mediated Inhibition |  | Definition 
 
        | Phenytoin (Dilantin) Carbamazepine (Tegretol)
 Oxcarbazepine (Trileptal)
 Lamotrigine (Lamictal)
 |  | 
        |  | 
        
        | Term 
 
        | Inhibition of Calcium Channels |  | Definition 
 
        | Ethosuximide Valproic Acid
 Gabapentin (Neurontin)
 |  | 
        |  | 
        
        | Term 
 
        | Enhance GABA-mediated Inhibition |  | Definition 
 
        | Benzodiazapines Phenobarbital
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enhance Na+ Cahnnel-mediated inhibition -stabilizes neuronal mem. to depol. by dec. flux of Na+ in resting/depol state
 -reduces inlfux of Ca2+ during depol. & suppresses repetitive firing neurons
 -reduces propagation of abnormal impulses in brain
 |  | 
        |  | 
        
        | Term 
 
        | Phenytoin (Dilantin) continued |  | Definition 
 
        | -Slow oral absorption; rapid distribution; high brain concentrations -Highly protein bound (90%)
 -CYP450 substrate and inducer
 -IV administration (fosphenytoin)
 -Used for: partial seizures (simple), tonic clonic seizures, epilepsy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enhance Na+ Channel-mediated inhibition -Na+ blocker that slows recovery rt of Na+ channels from inactivated to closed
 -Suppresses seizure focus and prevents rapid spread of seizure activity
 -Metab by CYP450
 -CYP450 Inducer; autoinduction
 -Used for: partial seizures (simple/complex), tonic clonic seizures, mood stabilization
 |  | 
        |  | 
        
        | Term 
 
        | Oxcarbazepine (Trileptal) |  | Definition 
 
        | Enhance Na+ channell-mediated inhibition -Na+ blocker that slows recovery rt of Na+ channels from inactivated to closed
 -CYP450 inducer; NO autoinduction
 -used for: partial seizures (simple/complex)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enhance Na+ channel-mediated inhibition -Stabilizes neuronal mem by blocking Na+ channels & Ca2+ channels
 -metab by CYP450
 -Decreased by Carbamazepine/phenytoin
 -increased by Valproic acid
 -used for: absence seizures, tonic-clonic, mood stabilization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium Channel Inhbitor -reduces low threshold T-type Ca2+ currents in voltage dependent manner
 -metab by CYP450
 -used for: absence seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium Channel Inhibitor -Slows rate of Na+ channel recovery from inactivated state
 -Limits activity of low threshold T-type Ca2+ channels
 -Inc GABA production
 -Metab by CYP450; enzyme inhibitor
 -used for: absence seizures, tonic clonic seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium Channel Inhibitor -inhibits high volt. activated Ca2+ chann
 -Inc. GABA content in neurons and glia
 -NOT metabolized; renally eliminated
 -Used for: simple partial seizures, tonic-clonic, neuropathic pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enhance GABA mediated inhibition -targets GABA-A receptor and inhibits neuronal firing
 -used for: epilepsy (first line), tonic clonic, infantile spasms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Prevents hypersynchronization of epileptiform burst firing -Does not affect normal neuronal excitability
 -renal dosing required
 -Used for: partial seizures (adjunct)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Inhibits volt. gated Na+ channels -Inc GABA activity
 -Reduces high volt Ca2+ channels
 -ANTAG AMPA
 -Induced by phenytoin/carbamazepine
 -Used for: partial seizures, tonic clonic, mood stabilzation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -blocks volt gated Na+ channels -Blocks T-type Ca2+ currents
 -sulfonamide derivative
 -Used for: partial epilepsy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Binds to a2-d site of volt gated Ca2+ -->inhibits excitatory neurotrans release
 -Renally eliminated
 -Used for: Partial onset seizures
 |  | 
        |  |